1620 / 1726
RetroEMBRACE: Late toxicity recorded in 610/731
patients.
Actuarial rates of severe (G3-G5) at 5 years were:
•Bladder 5%
•GI-tract 7%
•Vagina 5%
Monocentric series MRI guided IGABT >100 patients
(Vienna, Aarhus, Paris) report: 5.6% - 7% severe (G3-G5)
morbidity
Sturdza et al. R&O 2016; Potter R&O 2011; Lindegaard Acta Onc 2013; Castelnau-Marchand Gyn Onc 2015
Reported severe morbidity IGABT